Immunoglobulin replacement products in current clinical use in the United States have poor neutralizing activity against SARS-CoV-2 Omicron strains

Autor: Alexa Doss, Chieh-Yu Liang, Jennifer Monroy, James Wedner, Christopher Rigell, Hannah Davis-Adams, Lucas Adams, Peggy Kendall, Michael Diamond, Ofer Zimmerman
Rok vydání: 2023
Předmět:
Zdroj: Clinical Immunology. 250:109463
ISSN: 1521-6616
DOI: 10.1016/j.clim.2023.109463
Databáze: OpenAIRE